6
Oct
2026

i+Med S. Coop.

Exhibitor at CPHI Milan 2026 stand 16K34, Finished Dosage & Formulation
About Us

i+Med is a pharmaceutical laboratory, manufacturer and marketer of high value-added medical devices in the areas of traumatology, aesthetics, ophthalmology, dermatology and women's health. A world-leading scientific cooperative in the development of smart nanohydrogels and controlled release systems for active substances and drugs.

The laboratory, located in Vitoria-Gasteiz, Spain, focuses on the development and manufacture of its own products, as well as third party development under its controlled release technologies. We offer our exclusive ADAPTEK technology for customised...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Spain
  • On CPHI since:
    2018
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
CMO/CDMO
Contract Service
Distributor/Import Export
Manufacturer/Innovator
OTC
Pharmaceutical company
Veterinary Company
Primary activities
Contract Manufacturer
Medical Devices
OTC
Out-licensing specialist
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 16K34, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • BtHLINE and BtHCROSS - Dermal fillers for aestheic medicine (Linear HA 1,4%, Crosslinked HA 1,5%, 1,75%, 2%)

    Product BtHLINE and BtHCROSS - Dermal fillers for aestheic medicine (Linear HA 1,4%, Crosslinked HA 1,5%, 1,75%, 2%)

    BtHLINE 1,4% is a biocompatible linear hyaluronic acid hydrogel intended as a dermatologicaltreatment for aesthetic purposes. Administered by intradermal injection.

    Composition
    Non-animal HA
    Low level of endotoxins

    Properties


    BtHLINE 1,4%

    ...
  • Daydrop - controlled release multidose eye drops with ectoine for dry eye

    Product Daydrop - controlled release multidose eye drops with ectoine for dry eye

    DayDrop is an eye drop indicated to relieve dryness and eye irritation caused by environmental factors (wind, dust, smoke, air conditioning, dry heat), prolonged use of screens or contact lenses and / or certain ocular pathologies that occur with these symptoms. Hydrates, lubricates and protects for more...
  • DayDrop - eye drops with 12h sustained-release system of ectoine

    Product DayDrop - eye drops with 12h sustained-release system of ectoine

    DAYDROP. INNOVATIVE FORMULA WITH HIALURONIC ACID AND 12h SUSTAINED RELEASE OF ECTOINE 

    Eye drops indicated to relieve dryness and eye irritation caused by environmental factors (wind, dust, smoke, air conditioning, dry heat), prolonged use of screens or contact lenses and / or certain ocular pa...
  • ADAPTEK® TECHNOLOGY

    Product ADAPTEK® TECHNOLOGY

    ADAPTEK® TECHNOLOGY is the general name for our 4 international patents and expertise in nanotechnology and controlled release systems.This is a transversal technology that allows to develop customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.)....
  • OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    Product OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    OpHLINE is an ophthalmic viscosurgical devise (OVD) indicated as a coadjuvant during surgical procedures, involving the anterior chamber of the eye, especially in cataract surgery, including the extraction of the lens and the insertion of intraocular lenses.
    OpHLINE is available in 3 models ...

i+Med S. Coop. Resources (1)

  • i+Med Company profile

    Brochure i+Med Company profile

    i+Med is a biotech company formed by highly qualified personnel, focused on the R&D and manufacture of new products for third parties. Our ADAPTEK® TECHNOLOGY enables the development of customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.). These intelligent nanoparticles could be programmed to respond to external stimulus (E.g. pH or t˚) that allow the controlled release of APIs. As a result, we can develop high added value and differentiated products that provide our customers with a key competitive advantage in t...